Search research articles
Contact Us
Filters
Showing results (31-40 of 126) with videos related to
Page
of 13
Sort By:
Neurobiology of Aging
|
April 21, 2022
Rates of β-amyloid deposition indicate widespread simultaneous accumulation throughout the brain
Molly R LaPoint, Suzanne L Baker, Susan M Landau, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 29, 2013
Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals
Miranka Wirth, Cindee M Madison, Gil D Rabinovici, et al.
Molecular and Cellular Neurosciences
|
December 12, 2018
Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease
Ann D Cohen, Susan M Landau, Beth E Snitz, et al.
JAMA Neurology
|
March 21, 2017
Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology
Stefanie Schreiber, Frank Schreiber, Samuel N Lockhart, et al.
Neurobiology of Aging
|
November 10, 2023
DAT1 and BDNF polymorphisms interact to predict Aβ and tau pathology
Claire J Ciampa, Thomas M Morin, Alice Murphy, et al.
Neurobiology of Aging
|
October 29, 2021
Abnormal tau in amyloid PET negative individuals
Bora Yoon, Tengfei Guo, Karine Provost, et al.
Radiology
|
January 19, 2021
Molecular Imaging Approaches in Dementia
Victor L Villemagne, Frederik Barkhof, Valentina Garibotto, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 7, 2024
The ADNI PET Core at 20
William J Jagust, Robert A Koeppe, Gil D Rabinovici, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 21, 2012
Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods
Susan M Landau, Christopher Breault, Abhinay D Joshi, et al.
Alzheimer'S Research & Therapy
|
August 18, 2020
Normalization of CSF pTau measurement by Aβ<sub>40</sub> improves its performance as a biomarker of Alzheimer's disease
Tengfei Guo, Deniz Korman, Renaud La Joie, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 126) with videos related to
Sort By:
Page
of 13
Neurobiology of Aging
|
April 21, 2022
Rates of β-amyloid deposition indicate widespread simultaneous accumulation throughout the brain
Molly R LaPoint, Suzanne L Baker, Susan M Landau, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 29, 2013
Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals
Miranka Wirth, Cindee M Madison, Gil D Rabinovici, et al.
Molecular and Cellular Neurosciences
|
December 12, 2018
Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease
Ann D Cohen, Susan M Landau, Beth E Snitz, et al.
JAMA Neurology
|
March 21, 2017
Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology
Stefanie Schreiber, Frank Schreiber, Samuel N Lockhart, et al.
Neurobiology of Aging
|
November 10, 2023
DAT1 and BDNF polymorphisms interact to predict Aβ and tau pathology
Claire J Ciampa, Thomas M Morin, Alice Murphy, et al.
Neurobiology of Aging
|
October 29, 2021
Abnormal tau in amyloid PET negative individuals
Bora Yoon, Tengfei Guo, Karine Provost, et al.
Radiology
|
January 19, 2021
Molecular Imaging Approaches in Dementia
Victor L Villemagne, Frederik Barkhof, Valentina Garibotto, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 7, 2024
The ADNI PET Core at 20
William J Jagust, Robert A Koeppe, Gil D Rabinovici, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 21, 2012
Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods
Susan M Landau, Christopher Breault, Abhinay D Joshi, et al.
Alzheimer'S Research & Therapy
|
August 18, 2020
Normalization of CSF pTau measurement by Aβ<sub>40</sub> improves its performance as a biomarker of Alzheimer's disease
Tengfei Guo, Deniz Korman, Renaud La Joie, et al.
Page
of 13